U.S. Markets open in 42 mins

TG Therapeutics May Have Potential but the Charts Need More Work

Bruce Kamich

For his "Executive Decision" segment of Mad Money Thursday night, Jim Cramer sat down with Michael Weiss, chairman, president and CEO of TG Therapeutics Inc. Cramer noted that TGTX is a speculative company, one that still has no revenues, but their story continues to be compelling. In the daily bar chart of TGTX, below, we can see what looks like a base pattern to me when we look at volume along with the price action.